Definition and research guide
This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.
Content available: 4 complete abstracts (881 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.
Definition
A tick-borne disease characterized by fever; headache; myalgias; anorexia; and occasionally RASH. It is caused by several bacterial species and can produce disease in DOGS; cattle; sheep; goats; horses; and humans. The primary species causing human disease are ehrlichia chaffeensis; anaplasma phagocytophilum; and Ehrlichia ewingii.
Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.
Also known as: Ehrlichioses; Ehrlichia Infection; Ehrlichia Infections; Ehrlichia ewingii Infection; Ehrlichia ewingii Infections; E. ewingii Infection; E. ewingii Infections; E ewingii Infection.
Where it fits in the MeSH classification
- Broader topics
- Anaplasmataceae Infections; Tick-Borne Diseases
- Narrower topics
- Heartwater Disease
Related concepts
- Fever
- Headache
- Anorexia
- Cattle
- Sheep
- Goats
- Horses
- Ehrlichia Chaffeensis
- Anaplasma Phagocytophilum
Research landscape
PubMed indexes 3,213 records tagged with the MeSH heading “Ehrlichiosis” (counts retrieved 2026-10-29). 459 of them (14.3%) were published from 2020 onward, and the busiest period so far is 2000-2009 with 1,052 records.
Reviews account for 311 records (9.7%) and meta-analyses for 4. Randomized controlled trials number 13 (0.4%) as a share of all records on the topic. Randomized trials make up only a small share of this literature, so much of what is known comes from laboratory, observational or descriptive work.
Show the data
| Period | Records |
|---|---|
| through 1999 | 830 |
| 2000-2009 | 1,052 |
| 2010-2019 | 872 |
| 2020 onward | 459 |
Publication-type chart data
| Type | Records | Share |
|---|---|---|
| Reviews | 311 | 9.7% |
| Meta-analyses | 4 | 0.1% |
| Randomized controlled trials | 13 | 0.4% |
Method: PubMed query "Ehrlichiosis"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-29.
Reading the evidence in infectious diseases
Infectious disease evidence combines microbiology, epidemiology and clinical trials. Laboratory studies identify pathogens and how they cause harm; surveillance and outbreak investigations describe who is affected and how infection spreads; trials establish whether treatments and vaccines work. Results depend on place and time, because pathogens evolve and resistance patterns and population immunity change. Check when and where the data were collected, how cases were defined and how up to date the evidence is.
Evidence from open-access studies
These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.
| Study / authors | Year | Source label / design | Europe PMC citations | Licence / source |
|---|---|---|---|---|
| Guideline for veterinary practitioners on canine ehrlichiosis and anaplasmosis in Europe | 2015 | Review article Design not recorded in structured metadata | 208 | cc by PMID 25649069 · DOI · PMC4324656 |
| A review on the occurrence of companion vector-borne diseases in pet animals in Latin America | 2019 | Review article Design not recorded in structured metadata | 78 | cc by PMID 30917860 · DOI · PMC6438007 |
| Molecular detection of tick-borne pathogens in cattle from Southwestern Ethiopia | 2017 | Research article Design not recorded in structured metadata | 67 | cc by PMID 29155863 · DOI · PMC5695778 |
| Ehrlichia canis: Is It a Pathogen for Humans and Other Primates? | 2026 | Review article Design not recorded in structured metadata | 2 | cc by PMID 41754488 · DOI · PMC12943606 |
Guideline for veterinary practitioners on canine ehrlichiosis and anaplasmosis in Europe [1]
Abstract reading summary — source excerpts
- Opening excerpt
- Canine ehrlichiosis and anaplasmosis are important tick-borne diseases with a worldwide distribution.
- Closing excerpt
- This guideline is intended to answer the most common questions on these diseases from a practical point of view.
- Interpretation limits
- Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (92 words)
Canine ehrlichiosis and anaplasmosis are important tick-borne diseases with a worldwide distribution. Information has been continuously collected on these infections in Europe, and publications have increased in recent years. Prevalence rates are high for Ehrlichia and Anaplasma spp. infections in dogs from different European countries. The goal of this article was to provide a practical guideline for veterinary practitioners on the diagnosis, treatment, and prevention of ehrlichiosis and anaplasmosis in dogs from Europe. This guideline is intended to answer the most common questions on these diseases from a practical point of view.
Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 25649069 · DOI · PMC4324656
A review on the occurrence of companion vector-borne diseases in pet animals in Latin America [2]
Abstract reading summary — source excerpts
- Opening excerpt
- Companion vector-borne diseases (CVBDs) are an important threat for pet life, but may also have an impact on human health, due to their often zoonotic character.
- Closing excerpt
- This wide occurrence and the fact that most of the CVBDs can have a quite severe clinical outcome and their diagnostic as well as therapeutic options in the region are often difficult to access and to afford, demands a strong call for the prevention of pathogen transmission by the use of ectoparasiticidal and anti-feeding products as well as by performing behavioural changes.
- Interpretation limits
- Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (294 words)
Companion vector-borne diseases (CVBDs) are an important threat for pet life, but may also have an impact on human health, due to their often zoonotic character. The importance and awareness of CVBDs continuously increased during the last years. However, information on their occurrence is often limited in several parts of the world, which are often especially affected. Latin America (LATAM), a region with large biodiversity, is one of these regions, where information on CVBDs for pet owners, veterinarians, medical doctors and health workers is often obsolete, limited or non-existent. In the present review, a comprehensive literature search for CVBDs in companion animals (dogs and cats) was performed for several countries in Central America (Belize, Caribbean Islands, Costa Rica, Cuba, Dominican Republic, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Puerto Rico) as well as in South America (Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, French Guiana, Guyana (British Guyana), Paraguay, Peru, Suriname, Uruguay, Venezuela) regarding the occurrence of the following parasitic and bacterial diseases: babesiosis, heartworm disease, subcutaneous dirofilariosis, hepatozoonosis, leishmaniosis, trypanosomosis, anaplasmosis, bartonellosis, borreliosis, ehrlichiosis, mycoplasmosis and rickettsiosis. An overview on the specific diseases, followed by a short summary on their occurrence per country is given. Additionally, a tabular listing on positive or non-reported occurrence is presented. None of the countries is completely free from CVBDs. The data presented in the review confirm a wide distribution of the CVBDs in focus in LATAM. This wide occurrence and the fact that most of the CVBDs can have a quite severe clinical outcome and their diagnostic as well as therapeutic options in the region are often difficult to access and to afford, demands a strong call for the prevention of pathogen transmission by the use of ectoparasiticidal and anti-feeding products as well as by performing behavioural changes.
Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 30917860 · DOI · PMC6438007
Molecular detection of tick-borne pathogens in cattle from Southwestern Ethiopia [3]
Abstract reading summary — source excerpts
- Opening excerpt
- Tick-borne diseases (TBDs) cause significant losses among livestock and impact the livelihoods of resource-poor farming communities worldwide.
- Closing excerpt
- Further research is required to determine the pathogenicity, host cell types and vector of the three novel Anaplasma species identified in this study.
- Interpretation limits
- Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (294 words)
Tick-borne diseases (TBDs) cause significant losses among livestock and impact the livelihoods of resource-poor farming communities worldwide. In Ethiopia, detailed studies on the epidemiology of tick-borne pathogens (TBPs) in cattle using sensitive molecular detection methods are scarce. The objective of this study was to determine the prevalence and species composition of bovine TBPs of veterinary significance in local cattle populations. A comprehensive cross-sectional epidemiological study was conducted in cattle populations of Illubabor zone in Southwestern Ethiopia from June to August 2013. For this purpose, blood samples were collected from 392 cattle. A combination of polymerase chain reaction (PCR) and a Reverse Line Blot (RLB) hybridization assay was employed for the detection of TBPs in these samples. The PCR/RLB results of the 392 blood samples indicated a high overall prevalence of 96.9% for TBPs, including Theileria mutans (66.1%), Theileria orientalis (51.8%), Anaplasma sp. Omatjenne (25.5%), Anaplasma marginale (14.5%), Babesia bigemina (14.0%) and Theileria velifera (13.0%) and minor occurrences of Ehrlichia ruminantium (0.5%) and Ehrlichia minasensis (0.26%). Moreover, three novel Anaplasma genotypes were detected in bovine blood samples. A phylogenetic analysis revealed that they most likely represent three, but at least two, new species. The prevalence of the three novel Anaplasma species, preliminary designated as Anaplasma sp. Hadesa, Anaplasma sp. Saso and Anaplasma sp. Dedessa, was 12.5%, 14.3% and 5.6%, respectively. Overall, a total of 227 cattle (57.9%) were found to be co-infected with two or more TBPs simultaneously and 86 different species combinations were observed. The findings show a very high burden of infection of cattle with TBPs in Ethiopia. The high frequency of co-infections suggests that clinical manifestations might be complex. Further research is required to determine the pathogenicity, host cell types and vector of the three novel Anaplasma species identified in this study.
Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 29155863 · DOI · PMC5695778
Ehrlichia canis: Is It a Pathogen for Humans and Other Primates? [4]
Abstract reading summary — source excerpts
- Opening excerpt
- Ehrlichioses and anaplasmosis are among the most commonly reported tick-borne diseases in humans and some animal species.
- Closing excerpt
- canis in primates, and epidemiological investigations are needed to monitor its spread in animal and tick species not usually associated with this agent.
- Interpretation limits
- Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (201 words)
Ehrlichioses and anaplasmosis are among the most commonly reported tick-borne diseases in humans and some animal species. Ehrlichia canis is the causative agent of canine monocytic ehrlichiosis; it primarily affects dogs and is usually transmitted by Rhipicephalus sanguineus ticks. Some reports suggest that this bacterium is a zoonotic pathogen capable of causing clinical symptoms consistent with human monocytotropic ehrlichiosis caused by Ehrlichia chaffeensis. Non-human primates seem to be susceptible to E. canis-infection, although it is not clear whether the bacterium can cause disease in these mammals. The number of cases of E. canis infections in human beings and other primates could be underestimated, mainly because inappropriate laboratory diagnoses are often carried out. Serological tests do not distinguish infection by E. canis from those due to other ehrlichial species; therefore, a correct diagnosis is possible only through molecular methods. Furthermore, E. canis is not usually recognized by veterinarians and clinicians as a possible pathogen of primates, and it is not included in the panel of tick-borne pathogens routinely investigated. Further studies are pivotal to verify the pathogenicity of E. canis in primates, and epidemiological investigations are needed to monitor its spread in animal and tick species not usually associated with this agent.
Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 41754488 · DOI · PMC12943606
Key reviews and meta-analyses
The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.
- Research article Ehrlichia chaffeensis: a prototypical emerging pathogen [5]
- Research article Human granulocytic anaplasmosis and Anaplasma phagocytophilum [6]
- Research article Human ehrlichiosis and anaplasmosis [7]
- Research article Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment [8]
- Research article Emergence of the ehrlichioses as human health problems [9]
- Research article Diagnosis of canine monocytotropic ehrlichiosis (Ehrlichia canis): an overview [10]
References
- Sainz Á, Roura X, Miró G, Estrada-Peña A, Kohn B, Harrus S, et al.. Guideline for veterinary practitioners on canine ehrlichiosis and anaplasmosis in Europe. . 2015. PMID 25649069 · DOI · PMC4324656
- Maggi RG, Krämer F. A review on the occurrence of companion vector-borne diseases in pet animals in Latin America. . 2019. PMID 30917860 · DOI · PMC6438007
- Hailemariam Z, Krücken J, Baumann M, Ahmed JS, Clausen PH, Nijhof AM. Molecular detection of tick-borne pathogens in cattle from Southwestern Ethiopia. . 2017. PMID 29155863 · DOI · PMC5695778
- Ebani VV. Ehrlichia canis: Is It a Pathogen for Humans and Other Primates?. . 2026. PMID 41754488 · DOI · PMC12943606
- Paddock CD, Childs JE. Ehrlichia chaffeensis: a prototypical emerging pathogen. Clin Microbiol Rev. 2003. PMID 12525424 · DOI · PMC145301
- Dumler JS, Choi KS, Garcia-Garcia JC, Barat NS, Scorpio DG, Garyu JW, et al.. Human granulocytic anaplasmosis and Anaplasma phagocytophilum. Emerg Infect Dis. 2005. PMID 16485466 · DOI · PMC3367650
- Ismail N, Bloch KC, McBride JW. Human ehrlichiosis and anaplasmosis. Clin Lab Med. 2010. PMID 20513551 · DOI · PMC2882064
- Dumler JS, Madigan JE, Pusterla N, Bakken JS. Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment. Clin Infect Dis. 2007. PMID 17582569 · DOI
- Walker DH, Dumler JS. Emergence of the ehrlichioses as human health problems. Emerg Infect Dis. 1996. PMID 8903194 · DOI · PMC2639805
- Harrus S, Waner T. Diagnosis of canine monocytotropic ehrlichiosis (Ehrlichia canis): an overview. Vet J. 2011. PMID 20226700 · DOI
About this article
- Sources
- NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
- Verification
- Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
- Review state
- automated source verified; no human expert review has been recorded yet.
- Version
- 1, last updated 2026-10-29.
See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.
Evidence strength
EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.